{
    "title": "Amgen 2015 outlook tops estimates, no plan to split; shares jump",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2811440/Amgen-2015-outlook-tops-estimates-no-plan-split-shares-jump.html",
    "date": "2014-10-28",
    "keywords": [
        "company",
        "revenue",
        "share",
        "amgen",
        "october",
        "investor",
        "dividend",
        "percent",
        "margin",
        "analyst",
        "outlook",
        "plan",
        "gmt",
        "email",
        "bill",
        "york",
        "oct",
        "inc",
        "pressure",
        "tuesday",
        "resume",
        "business",
        "update",
        "improvement",
        "thing",
        "bernstein",
        "executive",
        "robert",
        "bradway",
        "option",
        "mature",
        "growth",
        "product",
        "daniel",
        "point",
        "hedge",
        "fund",
        "strategy",
        "value",
        "structurestill",
        "saidamgen",
        "loeb",
        "return",
        "development",
        "expensivehead",
        "hooper",
        "biotechnology",
        "forecast",
        "thomson",
        "anyone",
        "cowen",
        "eric",
        "schmidtamgen",
        "july",
        "restructuring",
        "cost",
        "year",
        "buyback",
        "program",
        "purchase",
        "onyx",
        "yearamgen",
        "heart",
        "disease",
        "approval",
        "multibilliondollar",
        "cholesterol",
        "drug",
        "market",
        "yearthe",
        "blockbuster",
        "biotech",
        "billionbradway",
        "portfolio",
        "generation",
        "line",
        "costsamgen",
        "bernadette",
        "baum"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}